×
S&P 500   3,825.37 (+1.06%)
DOW   31,097.46 (+1.05%)
QQQ   281.90 (+0.58%)
AAPL   138.50 (+1.30%)
MSFT   259.25 (+0.94%)
META   159.88 (-0.85%)
GOOGL   2,171.55 (-0.35%)
AMZN   109.53 (+3.13%)
TSLA   679.26 (+0.87%)
NVDA   145.53 (-4.00%)
NIO   21.39 (-1.52%)
BABA   116.21 (+2.23%)
AMD   73.82 (-3.47%)
MU   53.61 (-3.02%)
CGC   2.81 (-1.40%)
T   21.37 (+1.96%)
GE   63.78 (+0.17%)
F   11.33 (+1.80%)
DIS   96.26 (+1.97%)
AMC   13.50 (-0.37%)
PFE   52.33 (-0.19%)
PYPL   71.39 (+2.22%)
NFLX   179.47 (+2.63%)
S&P 500   3,825.37 (+1.06%)
DOW   31,097.46 (+1.05%)
QQQ   281.90 (+0.58%)
AAPL   138.50 (+1.30%)
MSFT   259.25 (+0.94%)
META   159.88 (-0.85%)
GOOGL   2,171.55 (-0.35%)
AMZN   109.53 (+3.13%)
TSLA   679.26 (+0.87%)
NVDA   145.53 (-4.00%)
NIO   21.39 (-1.52%)
BABA   116.21 (+2.23%)
AMD   73.82 (-3.47%)
MU   53.61 (-3.02%)
CGC   2.81 (-1.40%)
T   21.37 (+1.96%)
GE   63.78 (+0.17%)
F   11.33 (+1.80%)
DIS   96.26 (+1.97%)
AMC   13.50 (-0.37%)
PFE   52.33 (-0.19%)
PYPL   71.39 (+2.22%)
NFLX   179.47 (+2.63%)
S&P 500   3,825.37 (+1.06%)
DOW   31,097.46 (+1.05%)
QQQ   281.90 (+0.58%)
AAPL   138.50 (+1.30%)
MSFT   259.25 (+0.94%)
META   159.88 (-0.85%)
GOOGL   2,171.55 (-0.35%)
AMZN   109.53 (+3.13%)
TSLA   679.26 (+0.87%)
NVDA   145.53 (-4.00%)
NIO   21.39 (-1.52%)
BABA   116.21 (+2.23%)
AMD   73.82 (-3.47%)
MU   53.61 (-3.02%)
CGC   2.81 (-1.40%)
T   21.37 (+1.96%)
GE   63.78 (+0.17%)
F   11.33 (+1.80%)
DIS   96.26 (+1.97%)
AMC   13.50 (-0.37%)
PFE   52.33 (-0.19%)
PYPL   71.39 (+2.22%)
NFLX   179.47 (+2.63%)
S&P 500   3,825.37 (+1.06%)
DOW   31,097.46 (+1.05%)
QQQ   281.90 (+0.58%)
AAPL   138.50 (+1.30%)
MSFT   259.25 (+0.94%)
META   159.88 (-0.85%)
GOOGL   2,171.55 (-0.35%)
AMZN   109.53 (+3.13%)
TSLA   679.26 (+0.87%)
NVDA   145.53 (-4.00%)
NIO   21.39 (-1.52%)
BABA   116.21 (+2.23%)
AMD   73.82 (-3.47%)
MU   53.61 (-3.02%)
CGC   2.81 (-1.40%)
T   21.37 (+1.96%)
GE   63.78 (+0.17%)
F   11.33 (+1.80%)
DIS   96.26 (+1.97%)
AMC   13.50 (-0.37%)
PFE   52.33 (-0.19%)
PYPL   71.39 (+2.22%)
NFLX   179.47 (+2.63%)
OTCMKTS:NUGN

NuGene International Stock Forecast, Price & News

$0.05
-0.02 (-28.57%)
(As of 06/30/2022 03:59 PM ET)
Add
Compare
Today's Range
$0.05
$0.06
50-Day Range
$0.04
$0.16
52-Week Range
$0.00
$0.20
Volume
946,320 shs
Average Volume
2.10 million shs
Market Capitalization
$36.94 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
30 days | 90 days | 365 days | Advanced Chart

Receive NUGN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for NuGene International and its competitors with MarketBeat's FREE daily newsletter.

NUGN Stock Forecast (MarketRank)

Overall MarketRank

0.00 out of 5 stars

Analyst Opinion: 0.0Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
NuGene International logo

About NuGene International (OTCMKTS:NUGN)

NuGene International, Inc. develops and markets customized skin care products in the United States. The company offers skincare products, such as universal cream, universal and eye serum, gel, and face wash products; and hair care products comprising regenerative shampoos and conditioners, and anti-hair loss serums. It is also involved in the research and formulation of a topical burn cream for the treatment of burns. The company offers its products to wholesale distributors, physicians, and consumers. NuGene International, Inc. is based in Irvine, California.

NUGN Stock News Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Toilet preparations
Sub-Industry
N/A
Current Symbol
OTCMKTS:NUGN
CIK
N/A
Fax
N/A
Employees
10
Year Founded
N/A

Company Calendar

Today
7/01/2022
Fiscal Year End
12/31/2022

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Market Cap
$36.94 million
Optionable
Not Optionable
Beta
5.10














NuGene International Frequently Asked Questions

How has NuGene International's stock performed in 2022?

NuGene International's stock was trading at $0.0250 at the beginning of the year. Since then, NUGN shares have increased by 100.0% and is now trading at $0.05.
View the best growth stocks for 2022 here
.

Are investors shorting NuGene International?

NuGene International saw a increase in short interest in the month of June. As of June 15th, there was short interest totaling 60,900 shares, an increase of 32.1% from the May 31st total of 46,100 shares. Based on an average trading volume of 1,085,500 shares, the days-to-cover ratio is currently 0.1 days.
View NuGene International's Short Interest
.

Who are NuGene International's key executives?

NuGene International's management team includes the following people:
  • Mr. Mohammed Ali Kharazmi J.D., M.B.A., Co-Founder & Chairman (Age 64)
  • Mr. Mohammed Saeed Kharazmi M.D., Co-Founder, CTO, Sec., Treasurer, Acting Cfo and Director (Age 58)
  • Mr. John R. Ohanesian, Chief Strategic Advisor for Hair
  • Dr. Shahrokh Zekavati, Exec. Director of Manufacturing

What is NuGene International's stock symbol?

NuGene International trades on the OTCMKTS under the ticker symbol "NUGN."

How do I buy shares of NuGene International?

Shares of NUGN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is NuGene International's stock price today?

One share of NUGN stock can currently be purchased for approximately $0.05.

How much money does NuGene International make?

NuGene International (OTCMKTS:NUGN) has a market capitalization of $36.94 million.

How many employees does NuGene International have?

NuGene International employs 10 workers across the globe.

How can I contact NuGene International?

NuGene International's mailing address is 17912 COWAN SUITE A, IRVINE CA, 92614. The official website for NuGene International is www.nugene.com. The company can be reached via phone at 714-641-2640.

This page (OTCMKTS:NUGN) was last updated on 7/1/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.